SG1: ALXN completed dosing in the first stage of its U.S. Phase I trial

By WIR Staff | Dec 7, 1998 | 8:00 AM GMT

Alexion Pharmaceuticals Inc. (ALXN), New Haven, Conn.
Product: SG1.1-SC

Read the full 94 word article

How to gain access

Continue reading with a
two-week free trial.